Companies /Healthcare

Boston Scientific Corp

NYSE: BSX Medical Devices
$43.13
▲ $0.40 (+0.94%) today
Markets open · 2:04pm ET

24/7 Wall St. View

Price Prediction $56.03 +31.1% Our analysts’ 12-month view: target, optimistic case, and floor. BSX price prediction → Earnings Beat +3.9% EPS vs. the estimate, revenue, and how the market reacted. BSX earnings history →

BSX at a Glance

Valuation
Market cap
$61.9B
P/E ratio
17.3
Profitability
Revenue (TTM)
$21.0B
Profit margin
17.5%
EPS (TTM)
$2.47
Price
52-week range
$41 – $106
24/7 target
$56.03
Street target
$59.90
Earnings
Next report
Oct 28, 2026
Q2 2026 EPS
$0.86
vs. $0.83 est.
+3.9%

Headquartered in Marlborough, MA Fiscal year ends December NYSE: BSX bostonscientific.com

About Boston Scientific

Boston Scientific Corporation is a global medical technology company that develops, manufactures, and markets a broad range of medical devices used in interventional and surgical procedures. The company operates through two reportable segments: MedSurg (encompassing Endoscopy, Urology, and Neuromodulation) and Cardiovascular. Its product portfolio addresses cardiovascular, respiratory, digestive, oncological, neurological, and urological diseases and conditions. Key growth platforms include pulsed field ablation (FARAPULSE) for atrial fibrillation, coronary intravascular lithotripsy, neuromodulation therapies, and embolization devices. The company has been actively expanding through strategic investments, including a recent equity stake in MiRus LLC to enter the transcatheter aortic valve replacement market. Boston Scientific trades on the NYSE under the ticker BSX and has been in operation for more than 45 years. Updated

Revenue by Segment · Q2 2026
  1. Cardiovascular67%
  2. MedSurg33%

Latest Activity

BSXBoston Scientific
New 52-week low$42.6-0.1% vs prior low · 2026-07-14

Boston Scientific just set a fresh 52-week low at $42.60, undercutting its mid-July floor. No bounce has held since the stock broke down from triple digits a year ago.

Read more
House trade disclosureKevin Hern
  • AAPLApple Inc. - Common Stock (AAPL)Partial sell$1K – $15KSep 8
  • AAPLApple Inc. - Common Stock (AAPL)Partial sell$1K – $15KSep 8
  • ARBUCKLE MEM HOSP AUTH OKLA SALES TAX 03.00000% 01/01/2027 REV BDS SER. 2018Buy$15K – $50KSep 8
  • BSXBoston Scientific Corporation Common Stock (BSX)Partial sell$50K – $100KSep 4
  • BSXBoston Scientific Corporation Common Stock (BSX)Sell$1K – $15KSep 3
  • BSXBoston Scientific Corporation Common Stock (BSX)Sell$1K – $15KSep 3
  • BSXBoston Scientific Corporation Common Stock (BSX)Sell$1K – $15KSep 3
  • BSXBoston Scientific Corporation Common Stock (BSX)Sell$50K – $100KSep 9
+ 42 more trades in this filing
Made public 29 days after the earliest trade

Hern's 99-trade filing is a near-wholesale exit from energy and industrials, with Devon Energy sold down in three separate blocks of $100,001 to $250,000 and a same-size Exxon trim, while the only buys are Oklahoma municipal bonds and defensive names like Coca-Cola and Chubb. A House Republican rotating out of oil into tax-free paper is worth noting as his own party campaigns on a trading ban.

Read more
House trade disclosureGilbert Ray Cisneros, Jr.
  • AMDAdvanced Micro Devices, Inc. (AMD)Partial sell$1K – $15KAug 18
  • AGIO150 Main Street Trust > Bank of America Agios Pharmaceuticals, Inc. - Common StoBuy$1K – $15KAug 20
  • APH150 Main Street Trust > Bank of America Amphenol Corporation Common Stock (APH)Buy$1K – $15KAug 18
  • APG150 Main Street Trust > Bank of America APi Group Corporation Common Stock (APG)Buy$1K – $15KAug 4
  • APP150 Main Street Trust > Bank of America Applovin Corporation - Class A Common StPartial sell$1K – $15KAug 18
  • AORT150 Main Street Trust > Bank of America Artivion, Inc. Common Stock (AORT)Buy$1K – $15KAug 20
  • ATRCAtriCure, Inc. - Common Stock (ATRC)Buy$1K – $15KAug 20
  • BSX150 Main Street Trust > Bank of America Boston Scientific Corporation Common StoBuy$1K – $15KAug 18
+ 42 more trades in this filing
Made public 37 days after the earliest trade

Fifty-eight transactions in one filing amount to a full portfolio rebuild: bigger-ticket buys in Microsoft, Eaton, Quanta Services and Globus Medical, funded partly by repeated Lamar Advertising sales and trims in AMD, Nvidia and Meta. The rotation leans toward power, infrastructure and medical devices while chip and ad-tech exposure comes down. Disclosed 37 days after the earliest trades.

Read more

BSX Coverage

Load More

Frequently Asked Questions

What does Boston Scientific do?

Boston Scientific Corporation is a global medical technology company that develops, manufactures, and markets a broad range of medical devices used in interventional and surgical procedures.

What is the BSX stock price target?

24/7 Wall St.'s 12-month price target for BSX is $56.03, rated Buy. The Wall Street consensus target is $59.90. BSX price prediction →